Description | The antibody reacts with human and murine S100A4. The mAb shows in vitro neutralizing activity induced by S100A4 on HUVECs migration. It also neutralize the production of active forms of MMP9 induced by the S100A4 protein. |
Clonality | Monoclonal |
Host Species | Mouse |
Target Species | Human |
Immunogen | Full-length human S100A4 |
Epitope | ELPSFLGKRT |
Isotype | IgG1 |
Expression Species | HEK293F or CHO |
Conjugation | None |
Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
Endotoxin | <1 EU/mg, determined by LAL method |
Purification | Protein A affinity purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
Application | WB; IHC; Block |
Application Notes | The antibody is recommended for detection of S100A4 by WB, IHC, Block assays. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | S100A4 |
Alternative Name | S100A4; S100 calcium binding protein A4; 42A; 18A2; CAPL; FSP1; MTS1; P9KA; PEL98; protein S100-A4; protein Mts1; fibroblast-specific protein-1; placental calcium-binding protein; malignant transformation suppression 1; leukemia multidrug resistance associated protein; S100 calcium-binding protein A4 (calcium protein; calvasculin; metastasin; murine placental homolog); LK-1 |
Gene ID | 6275 |
UniProt | P26447 |
Research Area | Cardiovascular; Signal Pathway |